Oral Omega 3 Drusen: A phase II randomized, double-mask study to establish the safety and efficacy of High-Dose Oral Omega 3 in subjects with high-risk drusen secondary to dry age-related macular degeneration  26/03/2013

Description

The objectives of this study are to evaluate the safety and efficacy of High-Dose Oral Omega 3 on the Photoreceptors/Retinal Pigment Epithelium/Bruch’s membrane complex in subjects with high-risk drusen secondary to age-related macular degeneration and to evaluate whether improvement in visual function occurs and progression to advanced stages of AMD is delayed.

Autor

Dr. Jordi Monés, M.D., Ph.D.
Número de Colegiado COMB: 22.838
Director
Doctor en Medicina y Cirugía
Especialista en Oftalmología
Especialista en Retina, Mácula y Vítreo